The efficacy and safety of Short course therapy with Cefixime in URTI in Indian Scenario

Authors : Ketan Pakhale, Ketan Pakhale, G K Tandon, G K Tandon, Tanma Bansal, Tanma Bansal, Vineet Jain, Vineet Jain, Dhiraj Dhoot, Dhiraj Dhoot

DOI : 10.18231/j.ijoas.2020.018

Volume : 3

Issue : 3

Year : 2020

Page No : 81-85

Upper respiratory tract infections (URTI) are one of the commonest cause for a patient’s visit to outpatient department (OPD). Short course therapies with penicillin and cephalosporin class of antibiotics are commonly prescribed in URTI cases. This study was a retrospective, multicentre, observational cohort analysis, planned to evaluate the effectiveness and safety of Cefixime 400 mg per day in patients of URTI, using WURSS 21 score. We analysed the data of 200 patients who were prescribed Cefixime for URTI. Most of the patients (55%) were male. The baseline mean WURSS score of 41.09 33.45 decreased to 25.74 22.29 [(-37.3%), p value<0> patients reported adverse effects. The findings of the present survey confirm the effectiveness and safety of short course of Cefixime therapy in URTI.

Keywords: URTI, Cefixime, WURSS, India.


Citation Data